Open access · OA
via Europe PMC
Nutritional and Fasting Strategies for the Management of MASLD/MASH: An Integrative Review.
Tawk D, Ghader G, Khatib Y, Attieh P, Youssef T, Othman M, Harb F, Azar S, Ghadieh HE.
JGH open : an open access journal of gastroenterology and hepatology · 2025
Abstract
Non-alcoholic fatty liver disease (NAFLD), recently redefined as metabolic dysfunction-associated steatotic liver disease (MASLD), has emerged as the most common chronic liver disease worldwide, affecting nearly one in three adults. Despite its growing prevalence, there is still no approved pharmacological treatment, making lifestyle modification the cornerstone of management. Among the most promising strategies are nutritional interventions and structured fasting regimens, which target the underlying metabolic dysfunction driving disease progression. This review explores the impact of various dietary patterns-including the Mediterranean diet, low-glycemic index and low-carbohydrate diets, plant-based approaches, and the DASH diet-on hepatic steatosis, liver enzymes, and metabolic health. Evidence from randomized trials and meta-analyses highlights the Mediterranean diet as particularly effective in reducing liver fat and improving cardiometabolic outcomes, especially when combined with physical activity. Plant-based and DASH diets also demonstrate significant benefits, although accessibility, adherence, and cultural factors remain as challenges. Fasting interventions, such as intermittent fasting, time-restricted eating, alternate-day fasting, periodic fasting, and the fasting-mimicking diet, have gained increasing attention. These regimens improve insulin sensitivity, promote fat oxidation, and reduce intrahepatic fat, with growing evidence supporting their safety and effectiveness in MASLD management. While results are encouraging, long-term adherence, standardization of fasting protocols, and individualized patient considerations remain key areas for future research. In summary, nutritional and fasting strategies represent practical, non-pharmacological options to prevent and manage MASLD. By addressing both hepatic and systemic metabolic dysfunction, they hold promise not only for improving liver health but also for reducing the broader burden of obesity, diabetes, and cardiovascular disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1002/jgh3.70315
- Canonical
- link ↗
- Fetched
- 2026-07-01 MST
Cite this
APA
D, T., G, G., Y, K., P, A., T, Y., M, O., F, H., S, A., & HE., G. (2025). Nutritional and Fasting Strategies for the Management of MASLD/MASH: An Integrative Review. <em>JGH open : an open access journal of gastroenterology and hepatology</em>. https://doi.org/10.1002/jgh3.70315
Vancouver
D T, G G, Y K, P A, T Y, M O, et al. Nutritional and Fasting Strategies for the Management of MASLD/MASH: An Integrative Review. JGH open : an open access journal of gastroenterology and hepatology. 2025. doi:10.1002/jgh3.70315.
BibTeX
@article{tawk2025Nutrit,
title = {Nutritional and Fasting Strategies for the Management of MASLD/MASH: An Integrative Review.},
author = {Tawk D and Ghader G and Khatib Y and Attieh P and Youssef T and Othman M and Harb F and Azar S and Ghadieh HE.},
journal = {JGH open : an open access journal of gastroenterology and hepatology},
year = {2025},
doi = {10.1002/jgh3.70315},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
AlQalam Journal of Medical and Applied Sciences 2026
Open access · CC-BY
Intermittent Fasting as a Dietary Strategy for Obesity Management: A Mini Review
Journal of Obesity & Metabolic Syndrome 2023
Open access · CC-BY
Mitochondrial Quality Control: Its Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Acta Marisiensis. Seria Medica 2023
Open access · CC-BY
Intermittent fasting for the management of NAFLD: Is there enough evidence?
Cell Communication and Signaling 2025
Open access · CC-BY
Taming fatty liver: can taurine combat metabolic dysfunction in MASLD?
Innovation in Aging 2022
Open access · CC-BY
DIETARY INTERVENTIONS FOR HEALTHY AGING
International Journal of Innovative Technologies in Social Science 2026
Open access · CC-BY